Market Overview

Loewen, Ondaatje, McCutcheon Reiterates Buy Rating, $5.25 PT on Zix Corporation

Related ZIXI
Grand View Health Renews Contract With Zix Corporation
The Supreme Court Boosts Zix Corp.

In a report published Wednesday, Loewen, Ondaatje, McCutcheon USA Limited reiterated its Buy rating and $5.25 price target on Zix Corporation (NASDAQ: ZIXI).

Loewen, Ondaatje, McCutcheon noted, “Zix reported on December 31 that it and its largest institutional investor, Meldrum Asset Management (10%+ stake including affiliated persons), reached a short ‐term standstill agreement on December 28. Meldrum will appoint 2 directors (Mark Bonney and Michael Dailey) to the Board and none of the existing Board will resign (Meldrum had been seeking a special meeting to replace 3 existing Zix Directors with its own slate), leaving the Board at 8 filled seats for now. However, one Company Director (not yet named) will not seek re‐election at the next annual meeting, leaving the Board thereafter with 7 Directors. Meldrum also will receive $100,000 from Zix for reimbursement of incurred costs.”

Zix Corporation closed on Monday at $2.79.

Latest Ratings for ZIXI

DateFirmActionFromTo
Oct 2013Imperial CapitalMaintainsOutperform
May 2013Imperial CapitalInitiates Coverage onOutperform
Jun 2012Loewen, Ondaatje, McCutcheon LimitedInitiates Coverage OnBuy

View More Analyst Ratings for ZIXI
View the Latest Analyst Ratings

Posted-In: Loewen Ondaatje McCutcheonAnalyst Color Reiteration Analyst Ratings

 

Related Articles (ZIXI)

Around the Web, We're Loving...

Get Benzinga's Newsletters